Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Our HIV cure is trying to use stem cells and it mi

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155191
(Total Views: 576)
Posted On: 03/26/2025 12:53:40 AM
Posted By: ohm20
Re: Goosebumbs22 #151260
Quote:
Our HIV cure is trying to use stem cells and it might be a successful way for many kinds of cures. I read an interesting article this morning that I wanted to share that is expanding our knowledge of using and programming stem cells. It’s really quite an advancement.



Our cure involves transplanting adult stem cells from another person who does not have a CCR5 delta 32 double allele deletion. Leronlimab substitutes for that gene deletion. The benefit of that is a more closely related person can be used for the stem cells reducing the chance of autoimmunity (GVHD). Although in almost all cases drugs that fight the autoimmunity still need to be used. for a lifetime limiting that treatment for a cure.

The trial you linked must have used allogenic (from the same patient) adult stem cells then dialed them back to a naive (fetal) pluripotent state. If they hadn't you'd see some level of rejection or GVHD. By nature any HIV carrier will not be a CCR5 delta 32 double allele deletion. Those allogenic naive stem cells would not wipe out HIV carrying cells and would still have CCR5 expression so the trick with leronlimab would be unlikely to work. If naive pluripotent stem cells from another person that has the CCR5 deletion don't cause an autoimmune reaction than in combo with leronlimab it could be effective and safe.

Either way there's still the possibilities of AAV leronlimab and ART/bNAb/ leronlimab treatment.

In the case of the trial you linked that regrows neuronal pathways leronlimab may be helpful because we know it downregulates processes that have a negative effect on that regrowth.


(11)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us